Massimo Broggini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.

Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 31, 2026

Erratum: Molecular determinants of response to PI3K/AKT/mTOR and KRAS pathways inhibitors in NSCLC cell lines.

Erratum: Molecular determinants of response to PI3K/AKT/mTOR and KRAS pathways inhibitors in NSCLC cell lines.

Journal: American journal of cancer research

Published: February 12, 2026

Editorial: Innovative drug combinations for enhanced solid tumor treatment efficacy.

Editorial: Innovative drug combinations for enhanced solid tumor treatment efficacy.

Journal: Frontiers in oncology

Published: December 09, 2025

Early molecular changes predict cancer cachexia in LKB1-deleted mouse models of NSCLC.

Early molecular changes predict cancer cachexia in LKB1-deleted mouse models of NSCLC.

Journal: Clinical and translational medicine

Published: March 12, 2025

The Landscape of PARP Inhibitors in Solid Cancers.

The Landscape of PARP Inhibitors in Solid Cancers.

Journal: OncoTargets and therapy

Published: October 15, 2024

Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring.

Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring.

Journal: Frontiers in oncology

Published: October 04, 2024

Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.

Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.

Journal: Cell death & disease

Published: September 18, 2024

Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.

Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 07, 2023

Editorial: Patient-derived tumor models for drug development.

Editorial: Patient-derived tumor models for drug development.

Journal: Frontiers in oncology

Published: June 20, 2023

Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticles.

Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticles.

Journal: Frontiers in immunology

Published: December 20, 2022

Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies.

Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 08, 2022

NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2).

NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2).

Journal: Cells

Published: October 31, 2022

Showing 1-12 of 96

Last Updated: 09/26/2026